Investing IdeasBrowse All StocksMarkets
Have your own idea? Try our Stock Screener
Header cover image

Danish (OMX) Market Analysis & Valuation

UpdatedMay 02, 2026
DataAggregated Company Financials
Companies128
  • 7D2.4%
  • 3M-11.4%
  • 1Y-15.6%
  • YTD-6.3%

The market has climbed 2.4% in the last 7 days, lead by the Healthcare sector with a gain of 5.1%. Longer term the market is actually down 16% over the past year. As for the next few years, earnings are expected to grow by 8.0% per annum.

Trending IndustriesBiotech

Market Valuation and Performance

Has the Danish Market valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Sat, 02 May 2026DKK 3.9tDKK 2.0tDKK 235.9b16.2x16.4x1.9x
Mon, 30 Mar 2026DKK 3.6tDKK 2.0tDKK 237.5b15.1x15.1x1.8x
Wed, 25 Feb 2026DKK 3.8tDKK 2.0tDKK 237.5b16.4x15.9x1.9x
Fri, 23 Jan 2026DKK 4.6tDKK 1.9tDKK 260.6b17x17.5x2.3x
Sun, 21 Dec 2025DKK 4.1tDKK 2.0tDKK 260.8b15.9x15.7x2.1x
Tue, 18 Nov 2025DKK 4.0tDKK 2.0tDKK 262.4b14.8x15.2x2x
Thu, 16 Oct 2025DKK 4.1tDKK 1.9tDKK 287.6b15.1x14.4x2.1x
Sat, 13 Sep 2025DKK 4.0tDKK 1.9tDKK 287.3b15x13.9x2.1x
Mon, 11 Aug 2025DKK 3.9tDKK 1.9tDKK 268.4b15.5x14.5x2.1x
Wed, 09 Jul 2025DKK 4.4tDKK 1.9tDKK 261.8b15.6x17x2.4x
Fri, 06 Jun 2025DKK 4.6tDKK 1.9tDKK 263.2b15.6x17.6x2.5x
Sun, 04 May 2025DKK 4.5tDKK 1.9tDKK 259.1b14.6x17.3x2.4x
Tue, 01 Apr 2025DKK 4.5tDKK 1.9tDKK 260.7b14.4x17.2x2.4x
Thu, 27 Feb 2025DKK 5.4tDKK 1.9tDKK 264.8b14.1x20.6x2.9x
Sat, 25 Jan 2025DKK 5.2tDKK 1.8tDKK 237.7b14.1x22x2.9x
Mon, 23 Dec 2024DKK 5.1tDKK 1.8tDKK 238.2b13.6x21.3x2.8x
Wed, 20 Nov 2024DKK 5.7tDKK 1.8tDKK 236.8b14.1x24.1x3.1x
Fri, 18 Oct 2024DKK 6.2tDKK 1.7tDKK 181.2b15.6x34.5x3.6x
Sun, 15 Sep 2024DKK 6.7tDKK 1.7tDKK 180.1b15.6x37.3x3.9x
Tue, 13 Aug 2024DKK 6.5tDKK 1.7tDKK 182.0b16x35.6x3.7x
Thu, 11 Jul 2024DKK 6.9tDKK 1.7tDKK 184.6b15.4x37.4x4x
Sat, 08 Jun 2024DKK 7.0tDKK 1.7tDKK 184.7b14.8x37.6x4.1x
Mon, 06 May 2024DKK 6.2tDKK 1.7tDKK 183.2b14.7x34.1x3.7x
Wed, 03 Apr 2024DKK 6.4tDKK 1.7tDKK 192.6b14.9x33.1x3.7x
Fri, 01 Mar 2024DKK 6.2tDKK 1.7tDKK 192.4b13.2x32x3.6x
Sun, 28 Jan 2024DKK 5.7tDKK 1.8tDKK 216.8b13.8x26.5x3.2x
Tue, 26 Dec 2023DKK 5.5tDKK 1.8tDKK 216.2b13.4x25.5x3.1x
Thu, 23 Nov 2023DKK 5.4tDKK 1.8tDKK 216.9b13.2x24.9x3x
Sat, 21 Oct 2023DKK 5.2tDKK 1.9tDKK 284.9b12.7x18.4x2.8x
Mon, 18 Sep 2023DKK 5.4tDKK 1.9tDKK 283.6b13.4x19x2.9x
Wed, 16 Aug 2023DKK 5.3tDKK 1.9tDKK 278.6b13.4x19x2.8x
Fri, 14 Jul 2023DKK 5.0tDKK 1.9tDKK 317.9b13.5x15.6x2.6x
Sun, 11 Jun 2023DKK 5.1tDKK 1.9tDKK 325.2b14.3x15.7x2.6x
Tue, 09 May 2023DKK 5.2tDKK 1.9tDKK 312.6b14.2x16.7x2.7x
Price to Earnings Ratio

16.7x


Total Market Cap: DKK 5.2tTotal Earnings: DKK 312.6bTotal Revenue: DKK 1.9tTotal Market Cap vs Earnings and Revenue0%0%0%
Danish Market Price to Earnings3Y Average 22.4x202420252026
Current Market PE
  • Investors are pessimistic on the Danish market, indicating that they anticipate earnings will not grow as fast as they have historically.
  • The market is trading at a PE ratio of 16.4x which is lower than its 3-year average PE of 22.4x.
Past Earnings Growth
  • The earnings for Danish listed companies have declined 9.0% per year over the last three years.
  • Meanwhile revenues have been flat.
  • This means that either the cost of doing business or the level of investment back into businesses is increasing since sales have remained steady while profits have fallen.

Sector Trends

Which sectors have driven the changes within the Danish Market?

DK Market2.39%
Consumer Staples7.40%
Utilities5.46%
Healthcare5.07%
Energy4.34%
Materials4.01%
Consumer Discretionary1.86%
Financials-0.082%
Tech-0.12%
Telecom-0.31%
Real Estate-0.60%
Industrials-1.85%
Sector PE
  • Investors favour the Utilities sector the most for future growth which is trading above its 3-year average PE ratio.
    • This is likely because analysts are expecting annual earnings growth of 22.8% and investors are willing to pay a premium for that growth.
  • The Consumer Discretionary sector is the least preferred by investors for future growth, which is trading below its 3-year average of 17.4x.
Forecasted Growth
  • Analysts are most optimistic on the Tech sector, expecting annual earnings growth of 37% over the next 5 years.
  • This is better than its past earnings decline of 42% per year.
  • In contrast, the Energy sector is expected to see its earnings decline by 18% per year over the next few years.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuationSector
NOVO B Novo NordiskDKK 278.006.9%
+DKK 79.4b		-39.0%PE12xHealthcare
ORSTED ØrstedDKK 170.005.5%
+DKK 11.6b		-36.5%PE130xUtilities
CARL B CarlsbergDKK 877.009.1%
+DKK 9.7b		-4.9%PE19.5xConsumer Staples
MAERSK B A.P. Møller - MærskDKK 15.18k3.5%
+DKK 7.5b		28.2%PE12.7xIndustrials
NSIS B NovozymesDKK 399.604.1%
+DKK 7.3b		-7.8%PE42.7xMaterials
See more

Market Insights

Header cover image
We’re starting to see the second-order impact of Strait of Hormuz’s extended closure on other industries and in Q1 2026 reports - and it’s far more than just fuel and gas.
Continue reading
China's next winners have been chosen

Latest News

DANSKE
DKK 322.20
Danske Bank
7D
0.5%
1Y
32.4%
DSV
DKK 1,571.00
DSV
7D
-6.4%
1Y
5.9%
VWS
DKK 189.45
Vestas Wind Systems
7D
-0.7%
1Y
112.0%

VWS: Mixed Rating Shifts And New Orders Will Shape Execution Risks

Narrative Update Overview The analyst price target for Vestas Wind Systems has been adjusted to DKK 184 from around DKK 175, reflecting analysts' updated views on long term revenue growth, profit margins and discount rates following a mix of recent upgrades, downgrades and target increases from major firms. Analyst Commentary Recent research on Vestas Wind Systems presents a split view, with some analysts turning more positive on the shares and others taking a more cautious stance.
COLO B
DKK 402.80
Coloplast
7D
-2.5%
1Y
-42.2%
GMAB
DKK 1,694.00
Genmab
7D
-1.0%
1Y
19.2%

GMAB: 2026 Pipeline Catalysts Will Test Balanced Risk And Opportunity Outlook

Narrative Update on Genmab The updated analyst framework lifts Genmab's fair value estimate from DKK 1,300 to about DKK 1,588. This reflects higher assumed revenue growth and P/E multiples as analysts factor in recent upgrades, resumed coverage and new acquisition driven pipeline contributions.
CARL B
DKK 877.00
Carlsberg
7D
9.1%
1Y
-4.9%

CARL B: Britvic Acquisition And Non Alcoholic Shift Will Shape Future Multiple

Carlsberg's analyst price target edges up to DKK 1,045, as analysts balance slightly softer revenue growth and profit margin assumptions with a modestly higher future P/E and recent mixed rating and target moves related to the Britvic acquisition and broader sector views. Analyst Commentary Recent research on Carlsberg reflects a mix of optimism around the Britvic acquisition and non-alcoholic exposure, alongside more cautious tweaks to price targets as analysts recalibrate revenue and margin expectations.
ALK B
DKK 242.00
ALK-Abelló
7D
7.2%
1Y
55.3%
FLS
DKK 459.80
FLSmidth
7D
-7.8%
1Y
43.5%

FLS: March Update Will Highlight Uzbekistan Venture As Key Re Rating Catalyst

FLSmidth’s updated analyst price target edges higher from DKK 542 to about DKK 566, as analysts factor in slightly higher modeled revenue growth, profit margins and a modestly richer future P/E assumption, despite mixed recent rating changes and target moves across major banks. Analyst Commentary Recent Street research on FLSmidth reflects a mix of optimism and caution, with several banks adjusting ratings and price targets in different directions.
NOVO B
DKK 278.00
Novo Nordisk
7D
6.9%
1Y
-39.0%
TRYG
DKK 152.10
Tryg
7D
-2.2%
1Y
-5.6%

TRYG: Dividend Progress And Capital Authorisations Will Shape Balanced Future Expectations

Analysts have made only a modest adjustment to their view on Tryg, keeping the fair value estimate steady at DKK 172.71 while reflecting slightly higher revenue growth and profit margin expectations, as well as a lower future P/E in their updated price target assumptions. What's in the News Ordinary dividend for the first quarter of 2026 set at DKK 2.15 per share, compared with DKK 2.05 per share in the previous year.
MAERSK B
DKK 15,175.00
A.P. Møller - Mærsk
7D
3.5%
1Y
28.2%

MAERSK B: Prolonged Red Sea Disruption Will Pressure Margins Despite Mixed Rating Changes

Analyst price targets for A.P. Møller - Mærsk have been revised higher, with recent DKK target moves such as DKK 8,700 and DKK 16,600 prompting a modest reduction in fair value to DKK 8,049.84 as analysts factor in slightly higher discount rates, softer revenue growth, a much lower profit margin, and a very large forward P/E assumption. Analyst Commentary Recent research on A.P. Møller - Mærsk shows a divided view, with some firms lifting price targets while others cut targets or downgraded the shares.
HLUN B
DKK 42.40
H. Lundbeck
7D
-4.3%
1Y
32.1%

HLUN B: Dividend Policy And Neuroscience Pipeline Will Support Balanced Medium Term Outlook

Analysts have kept their DKK 46.13 price target for H. Lundbeck unchanged, citing consistent assumptions about revenue growth, profit margins and future P/E as the basis for their view.
NKT
DKK 933.00
NKT
7D
3.4%
1Y
69.9%

NKT: Elevated Execution Risks On Large Power Cable Projects Will Pressure Expectations

Analysts have nudged NKT's fair value estimate slightly higher to DKK 522.76, supported by a small lift in JPMorgan's price target to DKK 752, along with updated assumptions on discount rate, revenue growth, profit margin and future P/E. Analyst Commentary JPMorgan's latest move to lift its price target on NKT to DKK 752, while maintaining a Neutral stance, sits alongside more cautious signals from other bearish analysts who have trimmed their views or moved to less positive ratings.
ISS
DKK 238.60
ISS
7D
4.6%
1Y
42.1%
NSIS B
DKK 399.60
Novozymes
7D
4.1%
1Y
-7.8%
ORSTED
DKK 170.00
Ørsted
7D
5.5%
1Y
-36.5%